Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Shorting

<< Previous

Bullboard Posts

Next >>

Post by CAinPlapon Jan 06, 2022 11:12am

538 Views

Post# 34289093

Shorting

Hey STD,
Your preoccupation with the shorting numbers would imply you can provide some context. Would you say the entities shorting truly believe the company is not worth the present market cap or could it be just HFT on algorithms that affect most companies? Don't worry if you think you may be wrong as I will likely be the only one reading your response.
Serious replies only.
Your only friend, CAinPlap.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project